TY - JOUR
T1 - Introduction
T2 - the immune response against dying cells
AU - Zitvogel, Laurence
AU - Kroemer, Guido
N1 - Funding Information:
The author's own work is supported by the Ligue contre le Cancer (équipes labellisées), Agence National pour la Recherche, Institut National contre le Cancer, Cancéropôle Ile-de-France, and European Union.
PY - 2008/10/1
Y1 - 2008/10/1
N2 - The innate immune system is charged with the daunting task to discriminate harmless cell death events, as they occur in normal tissue homeostasis, and potentially harmful cell deaths, as they are elicited by infectious microorganisms or as a byproduct of malignant transformation. The distinction between harmful and harmless cell death relies on subtle biochemical differences that precede or accompany cell death and that act on a series of receptors, including pattern recognition receptors that are present on cells of the innate immune system, particularly dendritic cells. The present series of articles provides an up-to-date compendium on the molecular crosstalk between cell death and immune cells.
AB - The innate immune system is charged with the daunting task to discriminate harmless cell death events, as they occur in normal tissue homeostasis, and potentially harmful cell deaths, as they are elicited by infectious microorganisms or as a byproduct of malignant transformation. The distinction between harmful and harmless cell death relies on subtle biochemical differences that precede or accompany cell death and that act on a series of receptors, including pattern recognition receptors that are present on cells of the innate immune system, particularly dendritic cells. The present series of articles provides an up-to-date compendium on the molecular crosstalk between cell death and immune cells.
UR - http://www.scopus.com/inward/record.url?scp=50549089834&partnerID=8YFLogxK
U2 - 10.1016/j.coi.2008.07.009
DO - 10.1016/j.coi.2008.07.009
M3 - Editorial
C2 - 18657612
AN - SCOPUS:50549089834
SN - 0952-7915
VL - 20
SP - 501
EP - 503
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
IS - 5
ER -